TABLE 2.
MAC-ELISA results for WNV- and SLEV-infected seraa
| Antigen and serum type based on disease statea | Total no. of sera | No. (%) of results for:
|
|||
|---|---|---|---|---|---|
| WNV-WT | WNV-RH | SLEV-WT | SLEV-DRR | ||
| WNV infected | |||||
| This study | |||||
| Positive | 55 | 55 (100) | 55 (100) | 28 (51) | 11 (20) |
| Negative | 0 | 0 | 27 (49) | 44 (80) | |
| DRL | |||||
| Positive | 56 | 53 (95) | 53 (95) | 27 (48) | 10 (18) |
| Negative | 3 (5) | 3 (5) | 29 (52) | 46 (82) | |
| SLEV infected | |||||
| This study | |||||
| Positive | 37 | 17 (46) | 9 (24) | 35 (95) | 37 (100) |
| Negative | 20 (54) | 28 (76) | 2 (5) | 0 | |
| DRL | |||||
| Positive | 38 | 17 (45) | 9 (24) | 34 (89) | 36 (95) |
| Negative | 21 (55) | 29 (76) | 4 (11) | 2 (5) | |
a
See Table 1 and Materials and Methods for a description of how the different disease state classifications were determined.